Literature DB >> 3996800

Growth-factor-independent proliferation in vitro and tumorigenicity in vivo are associated in basophil/mast-cell lines and their somatic hybrids.

J F Conscience, F Fischer.   

Abstract

According to a current model, leukemic cells arise from normal hemopoietic progenitors as a result of two phenotypic changes: (1) a shift from a high to a low probability of completing differentiation, and (2) the loss of requirement for physiological growth regulators, such as multilineage hemopoietic growth factor (MHGF). In agreement with this model, we have recently reported that the spontaneous, in vitro, malignant transformation of a factor-dependent basophil/mast-cell line was coincidental with the appearance of MHGF-independent proliferation in vitro. We have now fused the MHGF-independent cells with their nontransformed counterparts. In the present study, 29 out of 32 hybrid clones analyzed exhibited an association between, on the one hand, the absence of MHGF requirement in vitro and high tumorigenicity in vivo and, on the other hand, MHGF-dependent proliferation in vitro and a reduced capacity to make tumors in vivo. These data support the idea that the tumorigenic behavior of the transformed cells in vivo and their lack of requirement for MHGF in vitro are directly related.

Entities:  

Mesh:

Year:  1985        PMID: 3996800     DOI: 10.1111/j.1432-0436.1985.tb00838.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  5 in total

1.  Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.

Authors:  I D Diamantis; A P Nair; H H Hirsch; C Moroni
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Altered protein kinase C in a mast cell variant defective in exocytosis.

Authors:  N Mazurek; R Regazzi; C Borner; R Wyss; J F Conscience; P Erne; U Eppenberger; D Fabbro
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

3.  A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production.

Authors:  A P Nair; I D Diamantis; J F Conscience; V Kindler; P Hofer; C Moroni
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

4.  Interleukin-3-dependent expression of the c-myc and c-fos proto-oncogenes in hemopoietic cell lines.

Authors:  J F Conscience; B Verrier; G Martin
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

5.  Reversible abrogation of IL-3 dependence by an inducible H-ras oncogene.

Authors:  E Andrejauskas; C Moroni
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.